TPP-resveratrol
TPP-resveratrol is a conjugate of Resveratrol (HY-16561) and triphenylphosphine (TPP) with anticancer activity. TPP-resveratrol increases the potency of Resveratrol through mitochondrial-targeted delivery and induces mitochondria-mediated apoptosis[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tpp-resveratrol.html
Purity
99.76
Solubility
DMSO : 116.67 mg/mL (ultrasonic)
Smiles
O=C(CCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)OC4=CC(O)=CC(/C=C/C5=CC=C(C=C5)O)=C4.[Br-]
Molecular Formula
C36H32BrO4P
Molecular Weight
639.51
References & Citations
[1]Jiang L, et al. The anti-cancer effects of mitochondrial-targeted triphenylphosphonium–resveratrol conjugate on breast cancer cells[J]. Pharmaceuticals, 2022, 15 (10) : 1271.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
